US Patent 11345706 Crystalline forms of Acalabrutinib
Patent 11345706 was granted and assigned to Apotex on May, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 23, 2018
Date of Patent
May 31, 2022
Patent Applicant
Patent Application Number
16639668
Patent Inventor Names
Kangying Li
0
Jingda Zhang
0
Wancheng Guo
0
Kun Cheng
0
Annyt Bhattacharyya
0
Bahareh Khalili
0
Fabio E. S. Souza
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11345706 Crystalline forms of Acalabrutinib
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.